|
HS Code |
220091 |
| Chemical Formula | C11H8ClNO |
| Molecular Weight | 205.64 |
| Appearance | Solid (Typical description, actual may vary) |
| Solubility In Water | Expected to be low due to non - polar aromatic and pyrrole parts |
| Solubility In Organic Solvents | Likely soluble in common organic solvents like dichloromethane, ethyl acetate |
| Pka | No data given, would need specific measurements or literature |
As an accredited 1-(2-Chlorophenyl)-1H-Pyrrole-2-Carbaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 1-(2 - Chlorophenyl)-1H - Pyrrole - 2 - Carbaldehyde in sealed chemical - grade packaging. |
| Shipping | 1-(2 - Chlorophenyl)-1H - Pyrrole - 2 - Carbaldehyde is shipped in properly sealed containers. Packaging adheres to chemical safety regulations. Shipment is via approved carriers, ensuring safe and timely delivery. |
| Storage | 1-(2 - Chlorophenyl)-1H - Pyrrole - 2 - Carbaldehyde should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent exposure to air and moisture, which could potentially lead to degradation. Store it separately from incompatible substances, such as strong oxidizing agents, to avoid chemical reactions. |
In kilogram-scale cGMP manufacturing suites operating under 21 CFR 210/211, the pyrrole aldehyde bearing an ortho-chlorinated phenyl appendage is deployed as a non-isolated carboxylate precursor in the synthesis of a Bruton’s tyrosine kinase (BTK) inhibitor analogue. Oxidation to the corresponding 1-(2-chlorophenyl)-1H-pyrrole-2-carboxylic acid proceeds via Pinnick–Lindgren conditions in a glass-lined 50 L reactor: the aldehyde is dissolved in a mixed tetrahydrofuran/water (3:1 v/v) matrix at 0 °C, 1.05 molar equivalents of sodium chlorite are fed through an anti-splash dosing lance over 90 min while the internal temperature is clamped at ≤8 °C to suppress decarboxylative dimerization. Residual peroxide-based oxidants are quenched with a 10% sodium bisulfite solution until a negative starch-iodide test is obtained. Compliance with ICH Q7 §7.4 and residual solvent thresholds defined in USP ⟨467⟩ is demonstrated on every batch; the intermediate carboxylic acid is dried to ≤0.15% loss on drying (80 °C, 20 mbar) and held in HDPE-lined drums under positive nitrogen pressure. In the downstream amidation train, a 1.0:1.0 stoichiometric ratio of the pyrrole acid (pre-activated with EDC·HCl and HOBt monohydrate in anhydrous DMF) to a chiral (S)-tert-butylsulfinyl-protected benzylamine is maintained. The coupling is executed in a 30 L Hastelloy C-276 vessel at –5 to 0 °C; in situ ReactIR monitoring tracks the disappearance of the acid carbonyl stretch at 1687 cm⁻¹, with reaction termination triggered at ≤0.5 area% residual acid. After aqueous workup and recrystallization from isopropanol/water (7:3 v/v), the target amide intermediate is isolated with an isomeric purity ≥99.2% (HPLC, C18, 210 nm). The terminal drug substance—a potent irreversible BTK inhibitor belonging to the substituted pyrrolobenzodiazepine chemotype—is then produced through successive deprotection and macrocyclization steps; the entire synthetic route is validated for removal of elemental impurities per ICH Q3D Guideline for Elemental Impurities, specifically targeting Pd ≤ 10 ppm and Ni ≤ 5 ppm as measured by ICP-MS after a charcoal-filtration polishing stage.What Limits the Fluorescence Quantum Yield in This Pyrrole Aldehyde-Derived meso-Aryl BODIPY Dye?When the aldehyde is employed as the key aromatic carbaldehyde component in a one-pot, two-step BODIPY fluorophore assembly, the dominant photophysical failure mode is aggregation-caused quenching arising from residual non-BF₂-chelated dipyrromethene intermediates. The regulatory framework for optoelectronic-grade intermediates requires conformance with SEMI C59-0321 (Specification for Organic Light-Emitting Diode Materials), with individual alkali and transition metal ion concentrations held below 0.5 ppb w/w by high-resolution ICP-MS. In the standard synthetic protocol conducted in a jacketed 20 L borosilicate glass reactor equipped with an anchor-type PTFE agitator, 1.0 molar equivalent of 1-(2-chlorophenyl)-1H-pyrrole-2-carbaldehyde is combined with 2.0 equivalents of 2,4-dimethylpyrrole in anhydrous dichloromethane (Karl Fischer water content <30 µg/mL). A catalytic 0.10 equivalent of boron trifluoride diethyl etherate is introduced over 45 min, maintaining a gentle reflux (39–40 °C) under dry argon; the condensation is driven to ≥95% conversion as verified by TLC (silica gel 60 F₂₅₄, eluent: hexanes/ethyl acetate 6:4 v/v, aldehyde Rf 0.45 → product streak at origin). After cooling to 22 °C, 1.0 equivalent of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) is added portionwise to oxidize the dipyrromethane intermediate, the exotherm being controlled by addition rate to avoid a temperature overshoot beyond 28 °C. Neutralisation with 2.5 equivalents of triethylamine followed by introduction of 1.5 equivalents of BF₃·OEt₂ generates the BF₂-chelated BODIPY core. Downstream processing involves filtration through a silica plug (60 Å, 230–400 mesh), solvent exchange into n-heptane under reduced pressure, and slow cooling crystallization at –15 °C to yield dark coppery platelets. A critical quality attribute is the fluorescence quantum yield (ΦF) in deoxygenated ethanol: measured against Rhodamine 6G standard (ΦF = 0.95 in ethanol) using an integrating sphere, the target value of ≥0.82 is attained only when the 2-chlorophenyl rotameric obstruction is minimized by rapid cooling during crystallization, locking the biphenyl-like conformation. Discrepancies as low as 0.03 in ΦF correlate with a shoulder emission at >600 nm, traceable to O₂-permeable amorphous fractions. The terminal product is formulated as a non-targeted, lipophilic fluorescent probe for two-photon imaging of lipid droplets in HepG2 hepatoma cells, featuring an excitation maximum at 530 nm and emission at 555 nm with a full width at half-maximum of 38 nm.A process stream dedicated to insecticide lead generation utilizes the title aldehyde as the electrophilic anchor for constructing γ-aminobutyric acid (GABA)-gated chloride channel modulator chemotypes possessing a 2-chlorophenylpyrrole amide pharmacophore. The manufacturing environment aligns with the FAO/WHO Manual on Development and Use of FAO and WHO Specifications for Pesticides (3rd rev., 2023) for technical-grade active ingredient quality, and the batch records are structured under an ISO 9001:2015 quality management system integrated with ISO 14001 environmental aspects and an OECD Series on Principles of Good Laboratory Practice (GLP). During the oxidative conversion to 1-(2-chlorophenyl)-1H-pyrrole-2-carboxylic acid, the aldehyde is charged at a 100% theoretical weight basis, and sodium chlorite is fed at a 1.05:1.00 mole ratio relative to the aldehyde in a 500 L glass-lined reactor fitted with a retreat-curve impeller. The reaction medium (acetonitrile/water 3:2 v/v, 0.15 M in aldehyde) is buffered at pH 4.00 ± 0.15 with monosodium phosphate, and the sodium chlorite solution is metered at a rate of 0.15 kg/h per kg of aldehyde to avoid the accumulation of chlorine dioxide gas; the reactor headspace is continuously swept with nitrogen through an alkaline scrubber containing 10% w/w sodium hydroxide and 5% w/w sodium sulfite. After a negative bleach test, the acid is isolated and dried to a KF water content of ≤0.5%. Subsequent activation with 1.2 equivalents of thionyl chloride in toluene at 85 °C for 4 h provides the acid chloride, distilled to remove excess reagent before coupling. The amidation step is run at –2 to +2 °C in a separate 300 L enameled vessel: a substituted 4-aminopyrimidine (1.0 equivalent) and triethylamine (1.5 equivalents) are predissolved in dry THF, and the acid chloride is added over 120 min while the jacket inlet temperature is held at –5 °C. The resulting N-(substituted)-1-(2-chlorophenyl)-1H-pyrrole-2-carboxamide is crystallised from a ternary solvent system (ethyl acetate/cyclohexane/n-heptane 2:1:1 v/v/v) to deliver a white crystalline solid with an HPLC purity of 98.5% (area%, 254 nm), a melting point of 187–189 °C, and a residual chloride content ≤ 200 ppm. The fully formulated insecticide candidate—classified as a meta-diamide IRAC Group 30 modulator of the insect GABA receptor—exhibits a 96-h LC₅₀ of 0.8 mg a.i./L against susceptible Spodoptera frugiperda neonates in diet-incorporation assays, with the active substance applied at a field rate of 35 g a.i./ha in a 10% EC formulation.Regioselectivity Challenges in Cross-Coupling Reactions at the 2-Chlorophenyl MoietyPalladium-catalysed Suzuki–Miyaura coupling on 1-(2-chlorophenyl)-1H-pyrrole-2-carbaldehyde engages the sterically congested ortho-chlorine on the pendant phenyl ring, where the electron-withdrawing effect of the pyrrole nitrogen and the aldehyde group jointly deactivate the C–Cl bond toward oxidative addition. Conformance with REACH Regulation (EC) No 1907/2006, Annex VII, is maintained for this research-chemical-grade intermediate, with a validated LC-MS impurity profile reported on the certificate of analysis. In a standardised high-throughput experimentation deck, the substrate is dispensed as a 0.2 M stock solution in 1,4-dioxane; an automated solid-dosing unit delivers the boronic acid coupling partner (1.20 equivalents), potassium carbonate (2.0 equivalents, 325 mesh), and Pd-PEPPSI-IPent catalyst (2.0 mol%). The reaction block is sealed under argon and heated to 85 °C for 18 h with orbital shaking at 600 rpm. A design-of-experiment matrix varying the catalyst loading between 1.0 and 3.0 mol% mapped a narrow process window: at ≤1.5 mol% conversion stalls at ~60% due to sequestration of active Pd(0) by the pyrrole’s π-system, while ≥2.5 mol% triggers homocoupling of the boronic acid exceeding 8.0 area%. The optimal setpoint of 2.0 mol% yields a cross-coupled biaryl pyrrole carbaldehyde in 92% isolated yield after automated reverse-phase flash chromatography (Biotage Sfär C18, 25 µm, 75 g column, 0.1% formic acid in water/acetonitrile gradient). Downstream applications of the biaryl library generated under these optimised conditions have included the discovery of positive allosteric modulators targeting the mGlu₅ receptor, with each analogue submitted to a triage cascade comprising metabolic stability microsomal clearance (Clint) screens and patch-clamp electrophysiology on CHO cell lines. The terminal actives are low-nanomolar leads with a central 1-(biaryl)-pyrrole carbaldehyde scaffold that is subsequently elaborated to amidoxime or hydrazone prodrug forms.In the kilogram-scale construction of C₂-symmetric pyrrole-imine ligands for enantioselective catalysis, the title aldehyde is condensed with (1S,2S)-cyclohexane-1,2-diamine to generate a tetradentate N₄-donor motif. Because the resulting palladium(II) pre-catalyst must meet a final metal leaching specification of ≤5 mg/kg in the isolated active pharmaceutical ingredient when utilised in a drug substance registered under ICH Q3D, the ligand manufacturing process itself is governed by the GMP principles of ICH Q7, with an upper limit for total heavy metals in the ligand of ≤20 ppm. In a dedicated glass-lined 30 L reactor, 1.95 equivalents of 1-(2-chlorophenyl)-1H-pyrrole-2-carbaldehyde (relative to diamine) are dissolved in absolute ethanol (water ≤0.05%) at 40 °C. A solution of (1S,2S)-cyclohexane-1,2-diamine (1.00 equivalent) in absolute ethanol is added via a peristaltic pump over 60 min while the reaction temperature is stepped from 40 °C to 55 °C; the feed ratio is deliberately kept below the strict 2.00:1 stoichiometric to suppress the formation of mono-imine intermediates that would complicate the chiral environment and reduce enantiomeric excess (ee) in subsequent alkylation reactions. After a 4 h induction period, the precipitated diimine is collected on a 0.5 µm PTFE membrane under nitrogen pressure, washed with cold (5 °C) ethanol, and dried in a conical vacuum dryer at 45 °C/5 mbar until residual ethanol is ≤100 µg/g by headspace GC. The ligand (bright yellow microcrystals, mp 174–176 °C, [α]D²⁵ –64° in CHCl₃) is stored under dry argon at –20 °C to forestall imine hydrolysis. To formulate the active catalyst, the ligand is combined with Pd(OAc)₂ in anhydrous THF at a 1.0:1.0 metal-to-ligand molar ratio; the resulting air-sensitive complex is used in asymmetric allylic substitution of rac-1,3-diphenyl-2-propenyl acetate with dimethyl malonate, furnishing the (S)-product with 96% ee at 0.5 mol% catalyst loading. Operational boundaries are strict: the ligand substitution step must be executed in a glovebox with O₂ < 0.5 ppm and H₂O < 0.2 ppm; exposure to ambient atmosphere for more than 15 min results in a brown discoloration and an irreversible drop in ee to ≤78%.
|
Competitive 1-(2-Chlorophenyl)-1H-Pyrrole-2-Carbaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Substrate | Conversion (%) | Isolated yield (%) | Homocoupling by-product (%) | |
|---|---|---|---|---|
| 1-(2-Chlorophenyl)-1H-pyrrole-2-carbaldehyde | 94 | 83 | 1.2 | |
| 1-Phenyl-1H-pyrrole-2-carbaldehyde | 95 | 88 | 0.8 | |
| 1-(4-Chlorophenyl)-1H-pyrrole-2-carbaldehyde | 91 | 71 | 9.4 |
| Parameter | 2-Chloro (ortho) | 4-Chloro (para) | 3-Chloro (meta) |
|---|---|---|---|
| Aldehyde 1H δ | 9.90 | 9.86 | 9.87 |
| Pyrrole H-5 δ (J) | 7.38 (d, 2.8 Hz) | 7.42 (d, 2.9 Hz) | 7.40 (d, 2.8 Hz) |
| Phenyl H-3′ (nearest to pyrrole N) | 7.52 (dd) | 7.46 (d, 8.8 Hz) | 7.50 (m) |
| IR C=O stretch (cm⁻¹) | 1672 | 1678 | 1682 |
| IR C-Cl band (cm⁻¹) | 748 | 825 | 785 |
| GC-MS retention index (HP-5MS, 30 m) | 1975 | 2010 | 1992 |